South Korea targets first Lu-177 production by 2031 at Wolsong reactor

KHNP plans to commercialize the cancer-treatment isotope through a subsidiary-backed venture as local drugmakers seek relief from costly imports and tight global supply.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.